{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:48:03Z","timestamp":1782190083084,"version":"3.54.5"},"reference-count":73,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Invasive cervical cancer is a very common cause of cancer death in women worldwide, primarily due to late detection of this cancer. The clinical manifestations of cervical cancer vary significantly and are difficult to predict. Finding new effective biomarkers for the early detection of cervical cancer is essential to reducing mortality. Small microRNA molecules have also recently emerged as potential biomarker candidates in the diagnosis of cervical cancer. Despite analytical limitations in microRNA assays and the lack of automated and standardized tests, validated and prospective systematic evaluation of this new parameter in cervical cancer deserves further development. This review describes the importance and potential usefulness of microRNAs in detecting cervical cancer at an early stage, monitoring the course of the disease, and assessing the effectiveness of treatment. The diagnostic importance of microRNAs is well documented in many publications, suggesting that, as microRNA research progresses, they may become a useful diagnostic tool for cervical cancer.<\/jats:p>","DOI":"10.3390\/ijms27125330","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:57:58Z","timestamp":1781513878000},"page":"5330","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MicroRNAs as Biomarkers of Cervical Cancers"],"prefix":"10.3390","volume":"27","author":[{"given":"Wojciech","family":"Jelski","sequence":"first","affiliation":[{"name":"Department of Biochemical Diagnostics, Medical University, 15-269 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylwia","family":"Okrasinska","sequence":"additional","affiliation":[{"name":"Department of Biochemical Diagnostics, University Hospital, 15-269 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Mroczko","sequence":"additional","affiliation":[{"name":"Department of Biochemical Diagnostics, Medical University, 15-269 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weronika","family":"Rutkowska","sequence":"additional","affiliation":[{"name":"Department of Biochemical Diagnostics, University Hospital, 15-269 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia","family":"Zieziula","sequence":"additional","affiliation":[{"name":"Department of Biochemical Diagnostics, University Hospital, 15-269 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4075-8479","authenticated-orcid":false,"given":"Barbara","family":"Mroczko","sequence":"additional","affiliation":[{"name":"Department of Biochemical Diagnostics, Medical University, 15-269 Bialystok, Poland"},{"name":"Department of Neurodegeneration Diagnostics, Medical University, 15-269 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ijc.35369","article-title":"Global landscape of cervical cancer incidence and mortality in 2022 and predictions to 2030: The urgent need to address inequalities in cervical cancer","volume":"157","author":"Li","year":"2025","journal-title":"Int. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.21037\/atm-22-1732","article-title":"The diagnostic accuracy of TCT + HPV-DNA for cervical cancer: Systematic review and meta-analysis","volume":"10","author":"Li","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.23736\/S0026-4784.19.04397-1","article-title":"Global strategies for cervical cancer prevention and screening","volume":"71","author":"Pimple","year":"2019","journal-title":"Minerva Ginecol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molonc.2012.01.010","article-title":"Cancer biomarkers","volume":"6","author":"Henry","year":"2012","journal-title":"Mol. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Pardini, B., De Maria, D., Francavilla, A., Di Gaetano, C., Ronco, G., and Naccarati, A. (2018). MicroRNAs as markers of progression in cervical cancer: A systematic review. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4590-4"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Dai, X., Kaushik, A.C., and Zhang, J. (2019). The emerging role of major regulatory RNAs in cancer control. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00920"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yjmcc.2015.02.002","article-title":"Noncoding RNAs as regulators of cardiomyocyte proliferation and death","volume":"89","author":"Piccoli","year":"2015","journal-title":"J. Mol. Cell. Card."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/onc.2012.20","article-title":"Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis","volume":"32","author":"Wilting","year":"2013","journal-title":"Oncogene"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1038\/emm.2016.153","article-title":"Exosome-derived microRNAs in cancer metabolism: Possible implications in cancer diagnostics and therapy","volume":"49","author":"Tomasetti","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/nar\/gky1141","article-title":"miRBase: From microRNA sequences to function","volume":"47","author":"Kozomara","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Leitao, A.L., and Enguita, F.J. (2022). A structural view of miRNA biogenesis and function. Non-Coding RNA, 8.","DOI":"10.3390\/ncrna8010010"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"103051","DOI":"10.1016\/j.ebiom.2020.103051","article-title":"Pan-cancer analysis of somatic mutations in miRNA genes","volume":"61","author":"Nawrocka","year":"2020","journal-title":"eBioMedicine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cell.2005.06.036","article-title":"MiRNAs, cancer, and stem cell division","volume":"122","author":"Croce","year":"2005","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","article-title":"The role of MicrorNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Seyhan, A.A. (2023). Circulating microRNAs as potential biomarkers in pancreatic cancer -advances and challenges. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241713340"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1158\/0008-5472.CAN-23-0296","article-title":"KRAS Hijacks the miRNA regulatory pathway in cancer","volume":"83","author":"Bortoletto","year":"2023","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00280-021-04289-z","article-title":"MiRNA- 3662 reverses the gemcitabine resistance in pancreatic cancer through regulating the tumor metabolism","volume":"88","author":"Liu","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gde.2013.01.004","article-title":"miRNA profiling of cancer","volume":"23","author":"Croce","year":"2013","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/2277-9175.125826","article-title":"Inhibition of microRNA miR-92a induces apoptosis and necrosis in human acute promyelocytic leukemia","volume":"3","author":"Sharifi","year":"2014","journal-title":"Adv. Biomed. Res."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Tornesello, M.L., Faraonio, R., Buonaguro, L., Annunziata, C., Starita, N., Cerasuolo, A., Pezzuto, F., Tornesello, A.L., and Buonaguro, F.M. (2020). The Role of microRNAs, Long Non-coding RNAs, and Circular RNAs in Cervical Cancer. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00150"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"15700","DOI":"10.3390\/ijms150915700","article-title":"Multistep model of cervical cancer: Participation of miRNAs and coding genes","volume":"15","author":"Lopez","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/IGC.0000000000000399","article-title":"MiR 34a inhibits viability and invasion of human papillomavirus-positive cervical cancer cells by targeting E2F3 and regulating surviving","volume":"25","author":"Geng","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_25","first-page":"3541","article-title":"MiR 214 inhibits cell migration, invasion and promotes the drug sensitivity in human cervical cancer by targeting FOXM1","volume":"9","author":"Wang","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"ref_26","first-page":"569","article-title":"Association between miR Let-7g gene expression and the risk of cervical cancer in human papillomavirus-infected patients","volume":"21","author":"Barazandeh","year":"2018","journal-title":"Feyz J. Kashan Univ. Med. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12985-019-1220-y","article-title":"Serum and tissue miRNAs: Potential biomarkers for the diagnosis of cervical cancer","volume":"16","author":"Farzanehpour","year":"2019","journal-title":"Virol. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.3892\/or.2015.3821","article-title":"MicroRNA-494 promotes cervical cancer proliferation through the regulation of PTEN","volume":"33","author":"Yang","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_29","first-page":"562","article-title":"miR-144 inhibits growth and metastasis of cervical cancer cells by targeting VEGFA and VEGFC","volume":"5","author":"Tao","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.biopha.2017.09.143","article-title":"MicroRNA-150 promotes cell proliferation, migration, and invasion of cervical cancer through targeting PDCD4","volume":"97","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3892\/ijo.2017.3857","article-title":"MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer stem cells","volume":"50","author":"Zhou","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbrc.2015.01.066","article-title":"miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7","volume":"458","author":"Zhou","year":"2015","journal-title":"Biochem. Biophys. Res. Comm."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1533033820970667","DOI":"10.1177\/1533033820970667","article-title":"A novel circulating MiRNA-Based signature for the diagnosis and prognosis prediction of early-stage cervical cancer","volume":"19","author":"Qiu","year":"2020","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12935-017-0431-9","article-title":"MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer","volume":"17","author":"Chen","year":"2017","journal-title":"Cancer Cell Int."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Gebrie, A. (2022). Disease progression role as well as the diagnostic and prognostic value of microRNA-21 in patients with cervical cancer: A systematic review and meta-analysis. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0268480"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Matsuhashi, S., Manirujjaman, M., Hamajima, H., and Ozaki, I. (2019). Control mechanisms of the tumor suppressor PDCD4: Expression and functions. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092304"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3390\/ijms15010758","article-title":"Increased exosomal microRNA-21 and microRNA-146a levels in the cervicovaginal lavage specimens of patients with cervical cancer","volume":"15","author":"Liu","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"BSR20181377","DOI":"10.1042\/BSR20181377","article-title":"The role of miRNAs in the invasion and metastasis of cervical cancer","volume":"39","author":"Wang","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_39","first-page":"2561","article-title":"Unique microRNA expression profiles in cervical cancer","volume":"33","author":"Gocze","year":"2013","journal-title":"Anticancer Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/2211536610666210604123534","article-title":"MicroRNA levels in cervical cancer samples and relationship with lesion grade and HPV infection","volume":"10","author":"Hoelzle","year":"2021","journal-title":"MicroRNA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1038\/s41598-025-85888-1","article-title":"miR-21 promotes cervical cancer by regulating NTF3","volume":"15","author":"Chen","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Aguilar-Martinez, S.Y., Campos-Viguri, G.E., Medina-Garcia, S.E., Garcia-Flores, R.J., Deas, J., Gomez-Ceron, C., Pedroza-Torres, A., Bautista-Rodriguez, E., Fernandez-Tilapa, G., and Rodriguez-Dorantes, M. (2024). MiR-21 Regulates Growth and Migration of Cervical Cancer Cells by RECK Signaling Pathway. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202402.0570.v1"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Tamenang, A., Vohl, V., Schwartz, C., Kropidlowski, J., Jaeger, A., Hintelmann, K., Vettorazzi, E., Goy, Y., Petersen, C., and Peine, S. (2026). Circulating microRNA profiles as diagnostic tools for high-grade cervical lesions and HPV genotype stratification. Cells, 15.","DOI":"10.3390\/cells15090849"},{"key":"ref_44","first-page":"29","article-title":"Comparable expression of miR-let-7b, miR-21, miR-182, miR-145, and p53 in serum and cervical cells: Diagnostic implications for early detection of cervical lesions","volume":"13","author":"Okoye","year":"2019","journal-title":"Int. J. Health Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1080\/17520363.2024.2400963","article-title":"Roles of microRNA-486-5p in the diagnosis and the association with clinical symptoms of cervical cancer","volume":"18","author":"Wang","year":"2024","journal-title":"Biomark. Med."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Kepsha, M.A., Timofeeva, A.V., Chernyshev, V.S., Silachev, D., Mezhevitinova, E.A., and Sukhikh, G.T. (2024). MicroRNA-based liquid biopsy for cervical cancer diagnostics and treatment monitoring. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252413271"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bbagrm.2011.05.005","article-title":"Regulation of cellular miRNA expression by human papillomaviruses","volume":"180","author":"Zheng","year":"2011","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1177\/147323001003800518","article-title":"High-risk human papillomavirus reduces the expression of microRNA-218 in women with cervical intraepithelial neoplasia","volume":"38","author":"Li","year":"2010","journal-title":"J. Int. Med. Res."},{"key":"ref_49","first-page":"114","article-title":"MicroRNA analysis in human papillomavirus (HPV)-associated cervical neoplasia and cancer","volume":"1","author":"McBee","year":"2011","journal-title":"J. Carcinog. Mutagen."},{"key":"ref_50","first-page":"4755","article-title":"MiR-182 induces cervical cancer cell apoptosis through inhibiting the expression of DNMT3a","volume":"8","author":"Sun","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1038\/sj.onc.1210919","article-title":"Human papillomavirus Type 16 reduces the expression of microRNA-218 in cervical carcinoma cells","volume":"27","author":"Martinez","year":"2008","journal-title":"Oncogene"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/21691401.2018.1468770","article-title":"The combinational effect of E6\/E7 siRNA and anti-miR-182 on apoptosis induction in HPV16-positive cervical cells","volume":"46","author":"Javadi","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/s12032-011-9830-2","article-title":"Aberrant microRNA expression in human cervical carcinomas","volume":"29","author":"Rao","year":"2012","journal-title":"Med. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Zhang, J., Dong, D., Wei, Q., and Ren, L. (2022). CXCL10 serves as a potential serum biomarker complementing SCC-Ag for diagnosing cervical squamous cell carcinoma. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-10142-0"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2147\/RMHP.S278809","article-title":"Combined detection of ACTN4 and SCC-Ag is a promising serological biomarker for cervical intraepithelial neoplasia 3 orworse: A case-control study","volume":"13","author":"Zhu","year":"2020","journal-title":"Risk Manag. Healthc. Policy"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Nascimento, N.P.G., Gally, T.B., Borges, G.F., Campos, L.C.G., and Kaneto, C.M. (2022). Systematic review of circulating MICRORNAS as biomarkers of cervical carcinogenesis. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09936-z"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrc3932","article-title":"MicroRNA biogenesis pathways in cancer","volume":"15","author":"Lin","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"17064","DOI":"10.1002\/jcp.28457","article-title":"MicroRNAs: New prognostic, diagnostic, and therapeutic biomarkers in cervical cancer","volume":"234","author":"Nahand","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cancergen.2020.09.003","article-title":"Potential role of microRNAs in the treatment and diagnosis of cervical cancer","volume":"248\u2013249","author":"Shen","year":"2020","journal-title":"Cancer Genet."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"9033","DOI":"10.1038\/s41598-020-65850-z","article-title":"Applying serum proteins and microRNA as novel biomarkers for early-stage cervical cancer detection","volume":"10","author":"Du","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.2217\/epi-2020-0026","article-title":"Exosomal microRNAs: Novel players in cervical cancer","volume":"12","author":"Nahand","year":"2020","journal-title":"Epigenomics"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3892\/ol.2020.12316","article-title":"Circulating exosomal miR-125a-5p as a novel biomarker for cervical cancer","volume":"21","author":"Lv","year":"2021","journal-title":"Oncol. Lett."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"108480","DOI":"10.1016\/j.abb.2020.108480","article-title":"The roles of microRNA in human cervical cancer","volume":"690","author":"Miao","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Wang, H., Zhang, D., Chen, Q., and Hong, Y. (2019). Plasma expression of miRNA-21, \u2212214, \u221234a, and -200a in patients with persistent HPV infection and cervical lesions. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-6066-6"},{"key":"ref_65","first-page":"8260652","article-title":"The progress of methylation regulation in gene expression of cervical cancer","volume":"2018","author":"Feng","year":"2018","journal-title":"Int. J. Genom."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ymeth.2010.01.032","article-title":"Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)","volume":"50","author":"Kroh","year":"2010","journal-title":"Methods"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.canlet.2016.07.002","article-title":"Circulating microRNAs in cancer: Hope or hype?","volume":"381","author":"Singh","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Smolarz, B., Durczy\u0144ski, A., Romanowicz, H., and Hogendorf, P. (2021). The role of microrNAs in pancreatic cancer. Biomedicines, 9.","DOI":"10.3390\/biomedicines9101322"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e32826","DOI":"10.1097\/MD.0000000000032826","article-title":"MicroRNA-375 in extracellular vesicles\u2014Novel marker for esophageal cancerdiagnosis","volume":"102","author":"Chen","year":"2023","journal-title":"Medicine"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Wankhede, D., Grover, S., and Hofman, P. (2022). Circulating Tumor Cells as a Predictive Biomarker in resectable lung cancer: A Systematic Review and Meta-Analysis. Cancers, 14.","DOI":"10.3390\/cancers14246112"},{"key":"ref_71","first-page":"e2021028","article-title":"Circulating microRNAs as potential non-invasive biomarkers for breast cancer detection","volume":"92","author":"Canatan","year":"2021","journal-title":"Acta Biomed."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1373\/clinchem.2014.221341","article-title":"Circulating microRNA biomarker studies: Pitfalls and potential solutions","volume":"61","author":"Witwer","year":"2015","journal-title":"Clin. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1038\/s41598-020-62534-6","article-title":"The relationship of human tissue microRNAs with those from body fluids","volume":"10","author":"Cui","year":"2020","journal-title":"Sci. Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/12\/5330\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:10:50Z","timestamp":1782187850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/12\/5330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":73,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijms27125330"],"URL":"https:\/\/doi.org\/10.3390\/ijms27125330","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]}}}